MycoFold, Inc Verified partner
MycoFold represents a breakthrough in recombinant protein production. Founded by experienced leaders in Life Science Tools, the company addresses critical limitations of traditional expression systems (E. coli, HEK293, CHO) that have remained largely unchanged for 30 years.
More detail +
Traditional protein expression models often produce incomplete, improperly folded, or unstable growth factors. MycoFold's proprietary yeast platform (K. phaffii) is genetically engineered to replicate human-like Post-Translational Modifications (PTM), ensuring proper 3D folding and maximum bioactivity.
What makes MycoFold, Inc different
Recombinant protein production
MycoFold develops recombinant proteins, addressing limitations of traditional expression systems such as E. coli, HEK293, and CHO.
More detail +
The company was founded by leaders in life science tools and focuses on protein production methods that have seen little change over the past 30 years.
Engineered yeast platform
MycoFold uses a proprietary yeast platform based on K. phaffii, genetically engineered for human-like modifications.
More detail +
The platform is designed to replicate human-like post-translational modifications, supporting proper 3D folding and improved bioactivity of expressed proteins.
Improved folding and bioactivity
Traditional expression systems often produce incomplete, improperly folded, or unstable growth factors.
More detail +
MycoFold's platform targets these issues by ensuring proper folding and maximum bioactivity, aiming to deliver more complete and stable recombinant proteins for research use.
Product lines & services
Request a quote from MycoFold, Inc
Tell us your target and application — a BioHippo scientist will shortlist options and pricing, usually within one business day.